UroToday- In the November early view of Nature Clinical Practice Urology, Dr. Klotz reviews the strategy for active surveillance (AS) of prostate cancer (CaP). This review will highlight the essential points to implement AS into the practitioners' clinical practice.

Klotz stresses several postulates regarding AS, which are as follows. First, candidates for AS are identified through CaP screening. Favorable-risk CaP is characterized by a Gleason score of